Palivizumab, A Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection In High-risk Infants
Role in the Field
Neutralin Health Sciences and Innovation
Neutralin Environmental Health and Media
Neutralin Infectious Disease and Immunology
Neutralin Pediatric Infectious Disease Dynamics
Abstract
Citations
1,655
Year
1998
PageRank
3.9 / 10
Relative influence (log-scaled)